Excel Industries Reports Mixed Q1 FY27 Results

Excel Industries' profit for the quarter ended June 30, 2026, stood at Rs 29.11 crore on a standalone basis.
Consolidated profit for the same period was Rs 29.47 crore.

Reader Takeaway: YoY profit dip but QoQ recovery signals resilience, focus on chemical segment growth.

What just happened

Excel Industries announced its financial results for the first quarter of the financial year 2026-27 (ended June 30, 2026). The company, operating solely in the 'Chemical' segment, reported a standalone revenue from operations of Rs 293.73 crore. Profit After Tax (PAT) for the quarter was Rs 29.11 crore, with Basic/Diluted Earnings Per Share (EPS) at Rs 23.16.

On a consolidated basis, revenue stood at Rs 293.83 crore, and PAT was Rs 29.47 crore, with EPS at Rs 23.44.

Why this matters

The results indicate a year-over-year decrease in profitability. However, there's a notable sequential improvement compared to the immediately preceding quarter (March 31, 2026). This suggests a potential recovery or stabilization in business performance.

The backstory

Excel Industries has consistently operated within the chemical sector. The company's financial performance is typically influenced by demand in its core chemical markets and operational efficiencies.

What changes now

Investors will be watching to see if the sequential improvement can be sustained and translate into year-over-year growth in subsequent quarters. The company's focus remains on its single 'Chemical' business segment.

Risks to watch

Potential risks include market volatility in the chemical sector, raw material price fluctuations, and competition. While not explicitly mentioned in this filing, these are standard industry considerations.

Peer comparison

(Data not available in the filing. A full analysis would typically compare Excel Industries' performance against key players in the Indian chemical industry like BASF India, Aarti Industries, or SRF Limited.)

Context metrics (time-bound)

Standalone revenue from operations for Q1 FY27 was Rs 293.73 crore, down from Rs 309.47 crore in Q1 FY26.
Standalone PAT for Q1 FY27 was Rs 29.11 crore, down from Rs 33.56 crore in Q1 FY26.
However, sequential revenue grew from Rs 281.13 crore in Q4 FY26, and PAT rose from Rs 12.71 crore in Q4 FY26.

What to track next

Shareholders should monitor future quarterly results for sustained revenue and profit growth, management commentary on market conditions, and any new business developments or expansions within the chemical segment.